Some advanced espionage programs attributed to the United States used digital certificates that were stolen from Taiwanese companies, though
not full programs.
Not exact matches
WASHINGTON (AP)-- The Trump administration doesn't have a «bloody nose» strategy focused on a military strike against North Korea's nuclear
program without provoking a
full - scale war.
Encore, which was released in October, isn't the only incentive platform on the market — Achievers, Globoforce and O. C. Tanner are other companies that offer employee recognition
programs — but according to Keller it's the only
full - service recognition platform now accessible to smaller companies which can opt to manage their own
programs, versus paying enterprise - level fees.
WLES underpins other, more complex skills, so if you organize formal or informal higher levels of training — such as quality - assurance systems or computer use — you could be missing out on the
full value of those
programs if your employees don't have foundational literacy and numeracy skills.
Neither wanted to pay the
full monty, but they certainly weren't going to sit back and let the competition swoop in and grab so much first - rate sports
programming, particularly given the recent run Rogers» Sportsnet took at Bell's top - rated TSN.
Buffalo Wild Wings is testing a few options this June, but hasn't yet committed to a
full strategy on how to implement that
program.
While we believe the 10
programs featured on our list are excellent schools, this list doesn't provide a
full picture of the Canadian MBA landscape, nor does it factor in individual needs.
Unlike 2U's existing
programs, Semester Online, as the name implies, will
not be a
full degree
program.
«In a rush to publish, media outlets have
not given the
full context - including the extent to which these
programs are overseen by all three branches of government - to these effective tools.»
Everything is still up for discussion, from the size of the class to whether or
not it will be offered as a
full diploma
program.
These risks and uncertainties include: Gilead's ability to achieve its anticipated
full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may
not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may
not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; safety and efficacy data from clinical studies may
not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase
program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
There are excellent opportunities for those who don't wish, or are unable, to attend a
full four - year college
program.
Rather, beat yourself up if you're
not saving and investing in things that will make your money grow, such as taking
full advantage of your company's 401 (k)
program.
Based on the above, we do
not believe that the proposed savings are achievable without a
full program review.
Since many first - time homebuyers can't afford a
full 20 % down payment, there are government - backed loans and financial assistance
programs that are designed to help buyers during the purchasing process.
Anticipating critics who might say that the European Central Bank is
not in
full control of the eurozone's monetary policy if it shares the risk of its
program, Mr. Draghi said, «The singleness of monetary policy remains in place.»
I enjoyed other entries that stressed the importance of direct job creation
programs, which make a lot of sense, especially in disadvantaged communities that won't be reached by
full employment.
Many companies say that they have alternate payment
programs for borrowers who might
not be able to make a
full payment.
Wharton insists that it offers an «undiluted»
program, meaning that it's
not a «light» version of its
full - time MBA experience.
Having promised industry these lower - paid temporary workers, the premier is now trying to claim that the Temporary Foreign Worker
program is in fact an immigration
program, when she knows
full well it isn't.
As opposed to some trading
programs, in which traders don't really have
full access or command over the trading platform, Nextoption's apps promises that it allows trading with similar assets plus trade instruments that are available on the web version.
«The auditor general's report found that the
program is
not overseen properly,
full stop,» Robinson said.
But even if you don't launch a
full - scale social customer service
program like these companies have, it behooves you to vigilantly monitor your social presence for customer service issues.
Apps are nice because they generally don't require as much
programming as a
full scale software suite would take.
This option might
not be right for everyone; be sure to educate yourself on the
full requirements before pursuing this
program.
But for now, I would rather be part of a Christ - centered megachurch
full of
programs where people are coming to know Jesus as Savior, than part of a church of any size where they are
not.
The AA point of view, as set forth in the recognized literature of the movement, does
not take
full cognizance of the fact that personality factors such as selfishness, resentment, and hostility, which are controlled through the AA
program, are actually symptoms of deeper problems of inadequacy, insecurity, and inner conflict.
Although I fought for and achieved admission as the first woman to take the
full program of theological studies that was reserved for priesthood candidates, I could
not imagine as my male colleagues did that I could become a theologian like Karl Rahner, Rudolf Bultmann or Rudolf Schnackenburg — decisively determining theological questions and exegetical discussions.
To be sure, something depends upon how a challenged
program is designed and which President makes the next Court appointments; nevertheless there is a high probability that educational subsidies empowering the family to choose among the
full array of providers will
not be found an «establishment of religion.»
If Americans are to play their parts as world citizens with
full responsibility, they must speedily extend and intensify the
program of foreign language instruction,
not only in the traditional fields of Latin, French, German, and Spanish but also, for large numbers of citizens, in Russian, Chinese, Japanese, Arabic, and other non-European languages.
Although these part - time
programs were functioning well in most cases, it appeared that there was
not as much happening or as many new and imaginative developments taking place as in centers with
full - time clergy staff members.
Its foodservice
program offers retailers
full support by supplying free merchandising materials like display units, packaging materials and branding messages that Christie Cookie hopes will
not only sell more of its product, but also help the customer's brand.
I love the
program and have personally been a Weight Watchers member on and off for many years (while I am
not always personally following the
program I am always a paid WW member with
full access to the
program and online tools for use in creating recipes for my blog).
«Trying to figure out [what to] do or
not do seems to be a real big challenge for us,» he states, noting that it prefers to add small
programs as opposed to other chains that add «
full - sized delis» to their locations.
The hockey
program's healing isn't complete: In addition to having to come to grips with the implications of the racial incident, the Black Bears won't have a
full complement of scholarships available until next season.
Yet as he heads down the road in his 18 - wheeler, he already steers something only he and few others can see, something that is
not yet a church,
not really a school and
not quite a
full - fledged collegiate athletic
program.
He talks about the commitment that wrestling in high school for a
program like Graham takes, and the impact of
not having a
full ride scholarship waiting at the end of the trail if successful.
Potter's introduction to the intense practices, constant
full - court pressure and attention to detail that permeate Gonsalves»
program hasn't been too hard for her to adjust to because she's known some of the players for many years.
I just came from a 4hour workshop being put on by a Marketing agency that told a room
full of people that they should «partner with bloggers» more research into the advertising agency I learned that
not only was Nestle was one of their clients (I did notice this when they passed around some of Nestle's sophisticated social brochures) but they were in part (
not entirely sure if it was in whole or
not) behind the Nestle Family Blogger
program.
Cloth diaper trial and rental
programs are a great way to test - drive cloth diapers without a large financial commitment.If you decide you don't like them, you can return them for store credit or a
full refund.
As long as the session for your child's age isn't
full, Mother's Day Out
programs generally let you sign up any time of the year.
When you join this free
program you'll receive free samples of formula (my free samples a few years back were more like
full - sized canisters), plus super high value coupons that aren't obtainable any other way.
While Pollack said there are many districts throughout Illinois with outstanding elementary science teachers and
programs, she said she had
not heard of any other elementary districts that have gone to the expense of equipping and staffing a
full - time lab for young students.
Anyway, we decided that Christmas break would be the best time to try it as he won't be in his
full - time daycare / therapy
program where they give him his lunch and snacks and we'll be able to fully monitor everything he eats.
I wasn't a
full - time programmer at work, but I took several
programming classes in school, and had a few duties at work that required me to edit code.
If he were making policy, however, Broglio would «lean more towards the cautious side» in limiting contact practices, which is
not to say that he doesn't think «that a football
program could be successful» with some limits on
full - speed contact practices.
If for any reason you are
not completely satisfied with your PATH
program membership, and you want a refund, just send me an email saying so within the first 30 days and I'll promptly refund your payment in
full.
Research shows that most
programs do
not deliver the
full dosage of services intended, and families often drop out of
programs before their eligibility ends.
Two studies that collected data on this aspect of implementation found that one - tenth to one - quarter of families declined invitations to participate in the home visiting
program.14, 15 In another study, 20 percent of families that agreed to participate did
not begin the
program by receiving an initial visit.11 Second, families may
not receive the
full number of planned visits.
If you feel you have nowhere else to turn, then it is time to consider a
full time residential
program that can give your son the therapeutically immersive environment that you can't provide at home.